Results 201 to 210 of about 49,590 (251)

Design and Implementation of an Automated Interpretation Algorithm for Lupus Anticoagulant Functional Testing

International Journal of Laboratory Hematology, Volume 48, Issue 5, Page 1181-1188, October 2026.
ABSTRACT Introduction Lupus anticoagulant (LA) testing is essential, albeit complex, in the laboratory diagnosis of antiphospholipid syndrome (APS). Given the multi‐step workflow and the variability introduced by anticoagulant therapy, reagent differences, and interpretive approaches, result interpretation requires expert evaluation.
Chiara Novelli, Arianna Gatti, Flora Ierna, Elena Riccardi, Irene Cuppari   +4 more
wiley   +1 more source

Numerical and Interpretive Comparability of Optical and Mechanical Coagulation Analyzers: A Zlog-Supported Method Comparison Study. [PDF]

Diagnostics (Basel)
Cai X, Yang W, Lu Q, Lin Y.
europepmc   +1 more source

How I Investigate Borderline Prolonged aPTT: An Integrated Laboratory Approach to Mixing Studies and Factor Analysis

International Journal of Laboratory Hematology, Volume 48, Issue 5, Page 951-960, October 2026.
ABSTRACT Borderline prolongation of routine clotting assays—particularly the activated partial thromboplastin time (aPTT)—is a common interpretative challenge in laboratory hematology. These reproducible but mildly prolonged results often lie just beyond the upper reference limit and can trigger unnecessary follow‐up, delays, or misinterpretation ...
Nikolaos Androulakis, Eleni Nioti, Antonios Dilintas, Christina Kalpadakis   +3 more
wiley   +1 more source

Dynamic Co‐Evolution of C‐Reactive Protein and Albumin in Early Sepsis: A Group‐Based Dual‐Trajectory Analysis for Risk Stratification

Journal of Cellular and Molecular Medicine, Volume 30, Issue 20, October 2026.
ABSTRACT The coupled evolution of inflammation and metabolic dysfunction during early sepsis is incompletely characterized. Although C‐reactive protein (CRP) and albumin (ALB) are established markers of these processes, their joint longitudinal patterns have rarely been examined.
Tengfei Chen, Shuwen Zhang, Maoyu Ding, Yumei Yang, Qinxiang Yang, Wei Guo, Xiaolong Xu, Qingquan Liu   +7 more
wiley   +1 more source

Peripheral Leukocyte TET Protein Expression Is Associated with Plasma Coagulation Parameters in Patients with Heart Failure with Reduced Ejection Fraction: A Two-Center Cross-Sectional Study. [PDF]

J Clin Med
Wołowiec A, Wołowiec Ł, Grześk G, Budzyński J, Banach J, Osiak-Gwiazdowska J, Jaśniak A, Jakubowska P, Kozakiewicz M.   +8 more
europepmc   +1 more source

Heparin continuous infusion for thromboprophylaxis in pediatric liver transplant recipients. [PDF]

Front Pediatr
Taher KW, Alhawas R, Ansary S, Ibrahim S, Tarboush L, Alshalawi M, Alabdulsalam M.   +6 more
europepmc   +1 more source

Safety evaluation of the food enzyme cellulase from the genetically modified Trichoderma reesei strain NZYM‐FS

EFSA Journal, Volume 24, Issue 10, October 2026.
Abstract The food enzyme cellulase (4‐(1,3; 1,4)‐β‐d‐glucan‐4‐glucanohydrolase, EC 3.2.1.4) is produced with the genetically modified Trichoderma reesei strain NZYM‐FS by Novozymes A/S. The genetic modifications did not give rise to safety concerns. The food enzyme was considered free from viable cells of the production organism and its DNA.
EFSA Panel on Food Enzymes (FEZ), Holger Zorn, José Manuel Barat Baviera, Claudia Bolognesi, Francesco Catania, Gabriele Gadermaier, Ralf Greiner, Baltasar Mayo, Alicja Mortensen, Yrjö Henrik Roos, Marize L. M. Solano, Henk Van Loveren, Laurence Vernis, Cristina Andreoli, Andrea Terron, Andrey Yurkov, Ana Gomes, Daniele Cavanna, Cristina Fernández‐Fraguas, Natália Kovalkovičová, Yi Liu   +20 more
wiley   +1 more source

Severe Acquired Factor VIII Deficiency With Concomitant Lupus Anticoagulant: A Case Report. [PDF]

Cureus
Kim TH, Khawar A, Suh J.
europepmc   +1 more source

Safety evaluation of the food enzyme endo‐polygalacturonase from the non‐genetically modified Rhizopus oryzae strain MC3‐3‐9

EFSA Journal, Volume 24, Issue 10, October 2026.
Abstract The food enzyme endo‐polygalacturonase (1,4‐α‐D‐galacturonan glycanohydrolase, EC 3.2.1.15) is produced with the non‐genetically modified Rhizopus oryzae strain MC3‐3‐9 by Shin Nihon Chemical Co., Ltd. The food enzyme was considered free from viable cells of the production organism.
EFSA Panel on Food Enzymes (FEZ), Holger Zorn, José Manuel Barat Baviera, Claudia Bolognesi, Francesco Catania, Gabriele Gadermaier, Ralf Greiner, Baltasar Mayo, Alicja Mortensen, Yrjö Henrik Roos, Marize L. M. Solano, Henk Van Loveren, Laurence Vernis, Cristina Andreoli, Andrea Terron, Andrey Yurkov, Cristina Fernàndez‐Fraguas, Jaime Aguilera, Natalia Kovalkovicova, Yi Liu   +19 more
wiley   +1 more source